Premarket Movers

Top 5 Gaining Stocks

• Li Bang International Corp (LBGJ): +152.12%
• AIM ImmunoTech Inc. (AIM): +98.54%
• Perfect Corp. (PERF): +30.37%
• Swarmer, Inc (SWMR): +27.68%
• Artelo Biosciences Inc. (ARTL): +25.36%

Top 5 Losing Stocks

• Meiwu Technology (WNW): -33.36%
• bioAffinity Technologies (BIAFW): -19.19%
• Smart Powerr Corp. (CREG): -17.43%
• Lunai Bioworks Inc. (LNAI): -15.05%
• bioAffinity Technologies (BIAF): -14.58%

Sector Impact Analysis

Positively Impacted Sectors

• Biotechnology: Highly bullish momentum driven by regulatory clearances (Japan cancer patent for AIM) and successful capital raises (OVID PIPE financing).
• Communication Equipment: Surging on "AI tailwinds." Increased demand for optical components and next-gen data center lasers is lifting valuations for AAOI and LITE.
• Software (Application): Significant gains tied to M&A activity, specifically "take-private" proposals at premiums (PERF).
• Drone Technology/Aerospace: Strong IPO performance (SWMR) indicates high investor appetite for new defense and surveillance tech.

Negatively Impacted Sectors

• Internet Retail/Microcaps: Heavy losses following dilutive financing events. WNW plummeted after selling shares at a deep discount.
• Materials & Mining: Downward pressure caused by large capital raises through convertible notes (IAUX) and internal governance instability/board resignations (GTE).
• Software Infrastructure: Cooling sentiment for some AI-adjacent firms (SAIL) reporting weak forward-looking guidance despite current AI trends.

Expert Recommendation

• Primary Opportunity: Focus on Communication Equipment. The demand for AI infrastructure is a fundamental shift, not just speculation, benefiting companies providing physical data center hardware.
• Secondary Opportunity: Biotechnology remains a high-alpha play. Look for companies securing "PIPE" financing or patent approvals, as these provide both liquidity and a competitive moat.
• Cautionary Note: Avoid microcap retail and "Internet" stocks currently seeking emergency funding; dilutive warrants and discounted share offerings are destroying shareholder value in this tier.